GREY:IPHAF - Post by User
Post by
blogon May 10, 2007 5:31pm
340 Views
Post# 12761543
Are we being told something
Are we being told something*The Company expects that approximately 900 patients, in addition to the patients from previous trials, will be required in order to file for regulatory approval in Europe and Canada, subject to trial results. This can be achieved by increasing the number of patients in the current trial or by adding another Phase 3 trial in Europe.